Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting post-surgery ICU outcomes using IL-6 and blood-count inflammation scores

Official title: The Effects of IL-6 and Inflammation Scores on Mortality in Postoperative Patients Admitted to the Intensive Care Unit

Run by Trabzon Kanuni Education and Research Hospital · NCT07460141 · Data updated 2026-11-12

This study will test whether IL-6 levels and routine blood-count inflammation scores at ICU admission and 24 hours can help predict complications and in-hospital death for adults after surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment42 (estimated)
SponsorTrabzon Kanuni Education and Research Hospital
Academic / other
Locations1 site (Trabzon)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedMarch 15, 2026
Study endsMarch 15, 2026
Registry record updatedMarch 10, 2026
Trial IDNCT07460141 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) admitted to the ICU after surgery with available routine clinical and laboratory data at admission and 24 hours, and who provide informed consent, are eligible.

Probably not a fit

Patients under 18 and those having cardiac or thoracic surgery are excluded and would not benefit from this study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort of adult postoperative patients admitted to a single intensive care unit. IL-6 levels will be recorded at ICU admission and at 24 hours, and routine labs will be used to calculate hemogram-derived indices (for example NLR, PLR, SII, SIRI, NMR, CAR, CLR, and mSIS). Clinical severity (APACHE II, SOFA) and comorbidity (Charlson) scores, surgical details, and outcomes including mortality, morbidity, infections, antibiotic use, and duration of mechanical ventilation will be recorded. Analyses will examine associations between biomarkers and outcomes after adjustment for illness severity and other confounders, with no interventions beyond standard care.

Why it matters

Potential benefit: If successful, these common laboratory measures could help clinicians identify postoperative ICU patients at higher risk of complications or death earlier.

How similar studies have gone: Previous research has linked IL-6 and hemogram-derived indices like NLR to outcomes in critical illness, but combined predictive models in postoperative ICU populations have been variably validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Postoperative patients admitted to the ICU
* Availability of complete clinical and laboratory data at ICU admission and at 24 hours
* Provision of informed consent by the patient or legally authorized representative

Exclusion Criteria:

* Age \< 18 years
* Thoracic surgery patients
* Cardiac surgery patients

Where it's running

  • Recep Erin
    Trabzon, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.